Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Abrupt discontinuation can lead to deterioration in glycaemic control
Certificate of Analysis Certificate Janoshik #197346 Every lot, independently HPLC-tested and signed
In Phase 2 trials, nausea affected 28% of patients at the 12mg dose, peaking at weeks 6-8 and substantially resolving by week 12
Same medication
Present negligible interaction risk because their mechanisms are enzymatic or mitochondrial, not neurotransmitter-based
price, texture, and additional benefits dominate purchase decisions
US$ 22.17
US$ 20.59
US$ 24.02
US$ 26.54
